Radiological protection in nuclear medicine

View at publisher Summarise with VIRAT
Authors: C J Martin
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Nuclear medicine involves use of radioactive substances for diagnosis and treatment of disease. Radionuclides with short half-lives that emit gamma-rays, such as technetium-99m, are incorporated into radiopharmaceuticals that will pass through or accumulate in specific organs in the body. Images formed by gamma cameras with large scintillation crystals can show active tissues and provide information on physiological function. A number of elements common in tissues have isotopes that emit positrons, such as Fluorine-18, and co-incidence detection of annihilation photons is used in positron emission tomography that is especially useful in cancer detection. Some radiopharmaceuticals are also administered to treat cancer.

Fields of Study & Subjects

Radiation Dose and Imaging Radiopharmaceutical Chemistry and Applications Medical Imaging Techniques and Applications

Publication details

Journal / source
Institute of Physics eBooks
Pages
16-1–16-24
Publication date
1 March 2026
Language
EN
Document type
Book chapter